Stimulating immune cells with two cancer immunotherapies together can shrink the size of the viral "reservoir" in SIV-infected non-human primates treated with antiviral drugs, researchers have concluded. The reservoir includes ...
Mar 16, 2020
0
74
A monthly injection of an experimental anti-retroviral drug protected female monkeys from vaginal infection by a simian form of HIV, according to two new studies.
Jan 15, 2015
1
76
An experimental HIV vaccine based on mRNA—the same technology used in two highly successful COVID-19 vaccines—has shown promise in experiments in mice and monkeys, according to a study published Thursday in Nature Medicine.
Dec 12, 2021
0
153
For hundreds of thousands of years, monkeys and apes have been plagued by simian immunodeficiency virus (SIV), which still devastates primate groups in Africa.
Aug 22, 2019
0
262
A protein from Simian Immunodeficiency Virus (SIV), which can infect monkeys and apes, has shown promise as a potential component of a vaccine against Human Immunodeficiency Virus (HIV), in a new study from scientists at ...
May 22, 2019
0
44
There are more than 25 drugs to control HIV, yet the virus remains one of the world's biggest health problems. One of the many challenges with existing therapies is that a dormant version of the virus is always lurking in ...
Mar 13, 2017
0
14
A research team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a group of recently discovered antibodies may be a highly effective therapy for the treatment of HIV. Published on-line ...
Oct 30, 2013
1
0
Restoring and improving gut health may be key to slowing HIV progression to AIDS, according to a new study by University of Pittsburgh infectious diseases scientists published today in the journal JCI Insight.
Jul 24, 2023
0
30
Wound healing events in mucous tissues during early infection by Simian Immunodeficiency Virus, or SIV, guard some primate species against developing AIDS, a recent study has learned. The research looked at why certain species ...
Nov 22, 2019
0
63
Researchers have developed an animal model to test HIV infection and therapies in infants, allowing them to develop biomarkers to predict viral rebound after antiretroviral therapy (ART) interruption. The simian-human immunodeficiency ...
Sep 5, 2019
0
1
